The Off Label Use of Glycopyrrolate in the Adults Intensive Care Unit.
Status:
Not yet recruiting
Trial end date:
2021-04-10
Target enrollment:
Participant gender:
Summary
Tracheostomized patients in the ICU can have excessive tracheal secretions due to various
causes as hyperactive airway, irritation of the mucus producing cells and inhibition of the
ciliary functions. Excessive secretions will necessitate frequent suctions which carries the
risk of tracheostomy tube obstruction if not managed properly. Excessive tracheal secretions
may prolong the ICU stay, increase the nurses workload and increase patients morbidity and
mortality.
This clinical trial hypothesizes that the use of glycopyrrolate may decrease the tracheal
secretions and hence avoid such complications.